Results 181 to 190 of about 949,682 (362)

TableS1 from Modeling High-Grade Serous Ovarian Carcinoma Using a Combination of <i>In Vivo</i> Fallopian Tube Electroporation and CRISPR-Cas9–Mediated Genome Editing

, 2023
Katie Teng, Matthew J. Ford, Keerthana Harwalkar, Yuqi Li, Alain Pacis, David Farnell, Nobuko Yamanaka, Yu-Chang Wang, Dunarel Badescu, Tuyet Nhung Ton Nu, Jiannis Ragoussis, David G. Huntsman, Jocelyne Arseneau, Yojiro Yamanaka   +13 more
openalex   +1 more source

Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014: A population-based cohort study [PDF]

, 2021
Pia Leandersson, Thomas Högberg, Paul W. Dickman, Susanne Malander, Christer Borgfeldt   +4 more
openalex   +1 more source

Therapeutic targeting of chromatin alterations in leukemia and solid tumors

International Journal of Cancer, Volume 158, Issue 2, Page 382-408, 15 January 2026.
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner, Tobias Berg, Daniel Sasca, Sophie‐Luise Mersiowsky, Jayant Y. Gadrey, Johanna Thomas, Michael W. M. Kühn, Michael Lübbert   +7 more
wiley   +1 more source

Sub-millimeter endoscope demonstrates feasibility of in vivo reflectance imaging, fluorescence imaging, and cell collection in the fallopian tubes. [PDF]

J Biomed Opt, 2021
Cordova R, Kiekens K, Burrell S, Drake W, Kmeid Z, Rice P, Rocha A, Diaz S, Yamada S, Yozwiak M, Nelson OL, Rodriguez GC, Heusinkveld J, Shih IM, Alberts DS, Barton JK.   +15 more
europepmc   +1 more source

Bilateral Primary Fallopian Tube Carcinoma: A Histopathologist’s Perspective

, 2015
Pranita Medhi, Swagata Dowerah, M. Annaji Sarma, Farzana Z Ahmed   +3 more
openalex   +2 more sources

Supplementary Table S6 from Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube

, 2023
Mark A. Eckert, Shawn Pan, Kyle M. Hernandez, Rachel M. Loth, Jorge Andrade, Samuel L. Volchenboum, Pieter Faber, Anthony Montag, Ricardo R. Lastra, Marcus E. Peter, Shigeki Yamada, Ernst Lengyel   +11 more
openalex   +1 more source

Do Individuals With Endometriosis Display Interpretation and Memory Recall Biases Compared With Pain‐Free Controls? A Cross‐Sectional Study

Applied Cognitive Psychology, Volume 40, Issue 1, January/February 2026.
ABSTRACT Chronic pain significantly impacts many individuals with endometriosis, yet cognitive biases—specifically interpretation bias (IB) and memory recall bias (MRB)—remain underexplored in this context. This study examined IB and MRB in individuals with endometriosis compared with pain‐free controls and explored their associations with pain ...
Sophia Nematollahi, Frances A. Maratos, Daniel Gaffiero   +2 more
wiley   +1 more source

Randomized phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum- resistant or refractory ovarian / fallopian tube / primary peritoneal cancer (NCT03093155): updated survival and subgroup analyses [PDF]

Dana M. Roque, Eric R. Siegel, Natália Buza, Stefania Bellone, Gloria S. Huang, Gary Altwerger, Vaagn Andikyan, Mitchell Clark, Masoud Azodi, Peter E. Schwartz, Gautam G. Rao, Elena Ratner, Alessandro D. Santin   +12 more
openalex   +1 more source

Supplementary Table Legends, Figures S1 - S6 from Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube

, 2023
Mark A. Eckert, Shawn Pan, Kyle M. Hernandez, Rachel M. Loth, Jorge Andrade, Samuel L. Volchenboum, Pieter Faber, Anthony Montag, Ricardo R. Lastra, Marcus E. Peter, S. Diane Yamada, Ernst Lengyel   +11 more
openalex   +1 more source

TDP‐43 Phosphorylation: Pathological Modification or Protective Factor Antagonizing TDP‐43 Aggregation in Neurodegenerative Diseases?

BioEssays, Volume 48, Issue 1, January 2026.
TDP‐43 hyperphosphorylation occurs in neurodegenerative diseases, however, it is not a driver of TDP‐43 aggregation, but enhances TDP‐43 solubility, suggesting that TDP‐43 hyperphosphorylation is protective. Toxicity may arise from a broader phosphorylation‐driven cellular pathway disruption.
Simone Mosna, Dorothee Dormann
wiley   +1 more source